Context Therapeutics Inc.
CNTX
$0.52
$0.023.26%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -14.56M | -8.68M | -13.03M | -9.69M | -8.83M |
| Total Depreciation and Amortization | 6.60K | 4.70K | 4.10K | 4.10K | 4.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.07M | 440.60K | 2.35M | 350.50K | 415.80K |
| Change in Net Operating Assets | 465.10K | -3.19M | 1.73M | 2.76M | 2.57M |
| Cash from Operations | -7.02M | -11.43M | -8.94M | -6.58M | -5.84M |
| Capital Expenditure | -18.50K | -37.30K | 0.00 | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.50M | -- | -2.00M | -- | -- |
| Cash from Investing | -4.52M | -37.30K | -2.00M | 0.00 | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | 0.00 | 0.00 |
| Cash from Financing | -- | -- | 0.00 | 0.00 | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -11.54M | -11.47M | -10.94M | -6.58M | -5.84M |